stem cells...therapy, but the trial was halted in late 2011 because of a lack of funding and a change in lead American biotech company Geron’s business directives. The therapy to be tested was known as GRNOPC1, which consisted of progenitor cells (partially differentiated cells) that, once inside the body, matured into neural cells known as oligodendrocytes. The oligodendrocyte progenitors of...
Simply begin typing or use the editing tools above to add to this article.
Once you are finished and click submit, your modifications will be sent to our editors for review.